Research peptide
CJC-1295 No DAC / Ipamorelin Mix
This dual-secretagogue blend brings CJC-1295 No DAC (a GHRH analogue, Modified GRF 1-29) together with Ipamorelin (a selective GHRP and ghrelin receptor agonist). Two complementary receptor routes in one vial let researchers study synergistic pulsatile GH release within a single model. Each vial contains a 20mg blend (10mg CJC-1295 No DAC · 10mg Ipamorelin) as a lyophilised powder, ≥99% purity by HPLC, Certificate of Analysis on request. UK-based dispatch for preclinical research only. Research applications Synergistic pulsatile GH-release studies (GHRH + GHRP pathways) Comparative GHRH-receptor versus ghrelin-receptor signalling research Growth-hormone / IGF-1 axis pathway modelling Metabolic and body-composition research Blended- versus single-secretagogue comparisons Specifications Form: Lyophilised powder Purity: ≥99% (HPLC verified) Storage: −20°C, protected from light and moisture Available sizes: 20mg (10mg CJC-1295 No DAC + 10mg Ipamorelin) Certificate of Analysis: available on request
Size: 20mg
Multi-buy discount available
- Buy 2Save 5%
- Buy 3Save 10%
- Buy 5Save 15%
- Buy 10Save 20%
- 99%+ purity guaranteed
- COA available
- Same-day dispatch
- Secure checkout
Product details
- CJC-1295 No DAC / Ipamorelin Mix receptor binding and agonism assays in controlled laboratory settings.
- In vitro pathway signalling studies requiring batch-documented research material.
- Analytical method development and HPLC reference characterisation.
- Institutional protocol workstreams that require published Certificates of Analysis.
